We are (aminomethyl)phosphonic acid CAS:1066-51-9 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: (aminomethyl)phosphonic acid
Physical and Chemical Properties:
Density: 1.635 g / cm3
Boiling point: 358ºC at 760 mmHg
Melting point: 300 ° C
Flash point: 170.3ºC
Refractive index: 1.505
Appearance: white to off-white powder
Moisture Content: ≤0.3%
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Telavancin hydrochloride CAS:560130-42-9
Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.2-bromofluorobenceno CAS:1072-85-1 ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.3- (Cianometil) Piridina CAS:6443-85-2 ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.2,4-Dihydroxybenzophenone We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.